Literature DB >> 34965186

Clinical characteristics of reflux esophagitis among patients with liver cirrhosis: a case-control study.

Zijin Liu1, Lin Wei1, Huiguo Ding1.   

Abstract

BACKGROUND: Reflux esophagitis (RE) can cause esophageal varices bleeding and largely reduce life quality of liver cirrhosis (LC) patients. AIMS: To clarify the prevalence, severity and risk factors of RE among LC patients.
METHODS: A case-control study that enrolled 420 endoscopy-confirmed LC patients with RE as a case cohort and 409 LC patients without RE as a control group was conducted. Logistic regression was used to determine the risk factors for RE among LC patients.
RESULTS: The 10-year cumulative incidence rate of RE was 4.79% among the LC patients. The severity of RE among the LC patients was higher than that among the non-LC patients (p<.05). The LC patients with RE patients were older (56 years vs. 53 years) and had higher rates of male patients (77.14% vs. 65.77%), smoking (46.90% vs. 32.76%), alcohol intake (50.24% vs. 41.08%), past endoscopic variceal ligation (EVL) (9.05% vs. 4.65%), endoscopic injection sclerotherapy (EIS) (16.19% vs. 2.69%), hiatus hernia (7.14% vs. 0.13%) and portal vein thrombosis (PVT) (14.05% vs. 4.01%). Logistic regression demonstrated that hiatus hernia, past EIS, PVT, smoking, white blood cell count, age, spleen thickness and platelet (PLT) count were risk factors for RE among the LC patients.
CONCLUSIONS: Patients with LC tended to have severer RE than non-LC patients. The special risk factors of RE among LC patients included past EIS and PVT, which deserved extra attention for hepatologists as well as gastroenterologists to prevent.

Entities:  

Keywords:  Reflux esophagitis; endoscopic injection sclerotherapy; liver cirrhosis; portal vein thrombosis; risk factors

Mesh:

Year:  2021        PMID: 34965186     DOI: 10.1080/00365521.2021.2018489

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  1 in total

1.  Differential role of chronic liver diseases on the incidence of cancer: a longitudinal analysis among 248,224 outpatients in Germany.

Authors:  Sven H Loosen; David Schöler; Mark Luedde; Johannes Eschrich; Tom Luedde; Karel Kostev; Christoph Roderburg
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-22       Impact factor: 4.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.